Process for the detection of malignant melanoma
US5670323A · kind A · utility
16Cited by
0References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 2, 1995 |
| Grant date | Sep 23, 1997 |
| Priority date | — |
| Expiry date | Jun 2, 2015 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/50
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
According to the present invention, processes for detecting the presence of neoplastic disease are provided. The processes involve the detection of a product associated with expression of genes that encode protein receptors for fibroblast growth factor in cells or a product present in a body fluid. Detection can be carried out in a variety of ways, such as by hybridization to detect the presence of mRNA or immunological assays to detect the presence of receptor protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.